Variant report
Variant | nsv874026 |
---|---|
Chromosome Location | chr2:49829630-49888676 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76795827 | chr2:49847892-49847893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554495299 | chr2:49847932-49847933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186496515 | chr2:49847960-49847961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374980098 | chr2:49847964-49847965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146569596 | chr2:49847965-49847966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs60675270 | chr2:49847975-49847976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139794363 | chr2:49847980-49847981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559349433 | chr2:49847991-49847992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189728010 | chr2:49848010-49848011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371927751 | chr2:49848061-49848062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530038073 | chr2:49848068-49848069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549085794 | chr2:49848086-49848087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561313597 | chr2:49848092-49848093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541457514 | chr2:49848160-49848161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531832934 | chr2:49848161-49848162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs550259232 | chr2:49848164-49848165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116242281 | chr2:49848168-49848169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532727111 | chr2:49848183-49848184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149821298 | chr2:49848184-49848185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375067669 | chr2:49848225-49848226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs115468114 | chr2:49848254-49848255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536982965 | chr2:49848258-49848259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4971869 | chr2:49848288-49848289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373510494 | chr2:49848303-49848304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536650285 | chr2:49848327-49848328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182382222 | chr2:49848328-49848329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187097295 | chr2:49848378-49848379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540851879 | chr2:49848410-49848411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145827208 | chr2:49848415-49848416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574641293 | chr2:49848422-49848423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191338049 | chr2:49848542-49848543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563585199 | chr2:49848574-49848575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531692792 | chr2:49848628-49848629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567247171 | chr2:49848699-49848700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543861144 | chr2:49848700-49848701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565346738 | chr2:49848734-49848735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149005723 | chr2:49848736-49848737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147124086 | chr2:49848751-49848752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566312195 | chr2:49848775-49848776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530238118 | chr2:49848783-49848784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs369046737 | chr2:49848799-49848800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141074175 | chr2:49848827-49848828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183656783 | chr2:49848839-49848840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558162932 | chr2:49848842-49848843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570190253 | chr2:49848871-49848872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146936537 | chr2:49848873-49848874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114345833 | chr2:49848892-49848893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs137974998 | chr2:49848912-49848913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541663625 | chr2:49848970-49848971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs543502666 | chr2:49859015-49859016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49847800-49848800 | Enhancers | Fetal Heart | heart |
2 | chr2:49848400-49849000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:49859000-49866400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:49865600-49865800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr2:49867200-49868800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr2:49867400-49867600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr2:49867400-49868400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr2:49867400-49868600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr2:49867400-49868600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr2:49867400-49868800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr2:49867400-49868800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr2:49867600-49868200 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
13 | chr2:49867600-49868400 | Enhancers | H9 Cell Line | embryonic stem cell |
14 | chr2:49867600-49868800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr2:49867800-49868400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
16 | chr2:49868200-49869000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr2:49882600-49883000 | Enhancers | Brain Hippocampus Middle | brain |
18 | chr2:49882800-49883200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |